4//SEC Filing
Harris Todd 4
Accession 0000950170-24-116345
CIK 0001863127other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 5:13 PM ET
Size
8.4 KB
Accession
0000950170-24-116345
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-10-21$28.16/sh−13,188$371,370→ 1,355,927 total - Sale
Common Stock
2024-10-18$27.01/sh−43,636$1,178,796→ 1,375,011 total - Sale
Common Stock
2024-10-21$27.32/sh−5,896$161,081→ 1,369,115 total
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.60 to $27.51. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.89 to $27.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.8957 to $28.5951. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001711463
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 5:13 PM ET
- Size
- 8.4 KB